We are a small, highly collaborative team, deeply experienced as both venture investors and operators of healthcare technology companies. Our investment focus is driven by our years of experience growing biopharmaceutical product companies and therapeutic medical device companies.
We are focused and highly selective
We invest in and work with a limited number of exceptional entrepreneurs. We limit our commitments in the belief that our involvement can increase the probability of success for our portfolio companies and generate greater returns for our investors. Accordingly we choose to limit our capital base. We understand this model well and think that it doesn't scale easily.
We lead and participate in rounds
We have plenty of experience leading early-stage investments, but we are comfortable co-investing as well. We are willing to participate in financings as small as million, but also have the capacity to invest up to million in a company over time.
We like partners
Diverse skills and experience, a strong capital base, and good minds all add strength to our companies. We welcome the collaborative participation of experienced venture capital firms and strategic (corporate, academic, philanthropic and individual) investors in our projects.
We are well capitalized
We have more than 0 million of committed capital to support our companies. Our investors include leading institutions, families and individuals from the U.S. and abroad. Part of this capital is our own, and we try and think of it all that way.
Keyword URL: http://www.fdbnetwork.com/1997
Categories: Finance & Money Mgt.
Ad Medium: Online Advertisement
One Embarcadero Center, Suite 4000
San Francisco, CA 94111
Country: United States
Phone: (415) 392-7442
Fax: (415) 392-4264
We have invested in a uniquely talented and diverse group of entrepreneurs and scientists who share with us a deep belief in the potential for technology to dramatically improve the course of human care. While our portfolio is primarily split between pharmaceutical and medical device companies, we also will consider and have invested in other emerging healthcare technologies.